To procure a partek flow enterprise edition with RNA-SEQ, single cell, and atac-SEQ toolkits for nhgri.

Ended Purchase Order Awarded Last action

Contract number
75N92021P00315
Awardee
Awarding agency
Obligated
$151,960

Award facts

Opportunity
Contract value 55% obligated
  • $151,960.00 Current, with exercised options
  • $274,320.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Wildwood, MO 63005, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00005 $40,800
Exercise an Option P00004 $39,600
Other Administrative Action P00003 · Partek flow enterprise edition with RNA-SEQ, single cell, and atac-SEQ toolkits for nhgri. $0
Exercise an Option P00002 · Procure a partek flow enterprise edition with RNA-SEQ, single cell, and atac-SEQ toolkits for nhgri. $38,580
Other Administrative Action P00001 $0
Original award $32,980

About this award

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHGRI), part of the National Institutes of Health (NIH), to Partek, Incorporated to procure a Partek Flow Enterprise Edition software suite with RNA-Seq, Single Cell, and ATAC-Seq analysis toolkits. The $274,320 contract has a performance period ending on September 9, 2026. Partek is a for-profit bioinformatics software company providing genomic analysis tools to federal agencies, with Illumina, Inc. as its parent organization. The purchase order was issued under a competitive solicitation with no set-aside provisions. This contract will enable NHGRI's Center for Genetics and Genomics to utilize Partek's proprietary bioinformatics solutions to support comparative medicine research, transcriptome analysis, single-cell sequencing, and other genomic data management capabilities.

Quick answers

Who was awarded contract 75N92021P00315?

75N92021P00315 was awarded to Partek, Incorporated by National Heart Lung and Blood Institute (National Institutes of Health) on September 10, 2021.

How much is contract 75N92021P00315 worth?

The government has obligated $151,960 on 75N92021P00315. Its potential value, with all options, is $274,320.

Was contract 75N92021P00315 competed?

The extent of competition for 75N92021P00315 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award